Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce that it has received an Opinion Provision from the Bank of Lithuania concluding the Citizen Green token (CGT) is not a security. The official letter received from Bank of Lithuania’s Supervision Service states: Taking into account the fact that the issued tokens do not grant their holders any property and non-property rights, related to the revenues or control of the Company, and do not create any obligations with respect to token holders, such type tokens should not be deemed to be securities.

“The opinion letter from the Bank of Lithuania Supervision Service is an independent validation that our token ecosystem is a utility and not a security,” said GCAC CEO Brad Moore. “We have an international team of experts working to implement a token economy that will facilitate the collection and use of medical cannabis data to benefit the global cannabis industry in a fully compliant way. Our blockchain platform is designed to collect medical data, add value to the data with artificial intelligence (AI) and then provide that data to the medical cannabis industry so they can develop better products with the goal of better outcomes for patients.”


GCAC Europe, a wholly owned subsidiary of GCAC, applied to have the Bank of Lithuania analyse the GCAC token model and functions, and evaluate if the token has the features of a security or other financial instrument. The Bank of Lithuania is a part of the Eurosystem and cooperates with the European Central Bank and other Euro central banks to make decisions on monetary policy and its implementation. It examined the GCAC business model, CGT token functions, White Paper and supporting materials and deemed the token to be a utility.

GCAC is finalizing the launch of its own CGT as the basis of a medical cannabis loyalty program. The CGT is an important part of Citizen Green data platform, the world’s first end to-end data aggregation and user delivery system for the medical cannabis industry. This is a unique model where the token is used to reward participants of the GCAC medical cannabis ecosystem in a verifiable and fair manner. Furthermore, the CGT will be used as an access token, enabling users to acquire AI analysed data, receive discounts on purchases and access a full range of medical cannabis services.

Lithuania is a leading European jurisdiction with respect to blockchain and cryptocurrencies. Blockchain distributed ledger technologies are being supported at senior governmental levels by the Ministry of Finance and the Bank of Lithuania. The Bank of Lithuania is developing a blockchain platform and has created an infrastructure to test new technology within a well-defined environment. The Lithuanian Centre of Registers is implementing an immutable blockchain enabling companies to be remotely managed and share transactions with full transparency.

About Global Cannabis Applications Corp.

Global Cannabis Applications Corp. is a global leader in designing, developing, marketing and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, regtech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in the medical cannabis community. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.

For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).

To schedule an interview, please contact:

Bradley Moore

Chief Executive Officer

Telephone: 514.561.9091

Email: bmoore@cannappscorp.com

For more information, please contact:

Corporate Communications

Telephone: 1.855.269.9554

Email: info@cannappscorp.com

www.cannappscorp.com

Forward-Looking Information

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

Click here to connect with Global Cannabis Applications Corp. (CSE:APP, FSE:2FA, OTCQB:FUAPF) for an Investor Presentation. 

Source: www.thenewswire.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less